{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "Y",
          "alt": "C",
          "position": 1699
        },
        "variant_string_id": "LRRK2 Y1699C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "LRRK2 is predicted to function as a stress responsive protein scaffold mediating the regulation of mitogen-activating protein kinase (MAPK) pathways.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay, focusing on the role of LRRK2 in MAPK pathways."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses assays to evaluate the activation of the ERK pathway in response to oxidative stress.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used effectively models the disease pathogenesis by examining the ERK pathway activation."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls (wild-type LRRK2 and known mutants) and multiple replicates were used in the experiments.",
          "judgment": "Yes",
          "reasoning": "The paper includes both 'Normal/Negative/Wild type' and 'Abnormal/Positive/Null' controls and explicitly states the use of multiple replicates."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Statistical analyses were performed to estimate the impact of variants on ERK pathway activation.",
          "judgment": "Yes",
          "reasoning": "The paper provides statistical analyses, including ANOVA and post hoc Fisher’s protected least significant difference (PLSD) tests, to support the functional data."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The Y1699C variant shows a loss of protection against oxidative stress by failing to activate the ERK pathway, consistent with a pathogenic role. The functional evidence is moderately strong based on the rigorous controls and statistical analyses used."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": 2019
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "LRRK2 is predicted to function as a stress responsive protein scaffold mediating the regulation of mitogen-activating protein kinase (MAPK) pathways.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay, focusing on the role of LRRK2 in MAPK pathways."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses assays to evaluate the activation of the ERK pathway in response to oxidative stress.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used effectively models the disease pathogenesis by examining the ERK pathway activation."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls (wild-type LRRK2 and known mutants) and multiple replicates were used in the experiments.",
          "judgment": "Yes",
          "reasoning": "The paper includes both 'Normal/Negative/Wild type' and 'Abnormal/Positive/Null' controls and explicitly states the use of multiple replicates."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Statistical analyses were performed to estimate the impact of variants on ERK pathway activation.",
          "judgment": "Yes",
          "reasoning": "The paper provides statistical analyses, including ANOVA and post hoc Fisher’s protected least significant difference (PLSD) tests, to support the functional data."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The G2019S variant shows a loss of protection against oxidative stress by failing to activate the ERK pathway, consistent with a pathogenic role. The functional evidence is moderately strong based on the rigorous controls and statistical analyses used."
    }
  ]
}